Stock price
Market cap
At each fiscal year end, then the latest quarter end: closing price × shares outstanding.
Show tableHide table
| Period | Market cap |
|---|---|
| FY2016, ended Dec 31, 2016 | $64.0B |
| FY2017, ended Dec 31, 2017 | $53.8B |
| FY2018, ended Dec 31, 2018 | $34.3B |
| FY2019, ended Dec 31, 2019 | $44.8B |
| FY2020, ended Dec 31, 2020 | $32.7B |
| FY2021, ended Dec 31, 2021 | $46.3B |
| FY2022, ended Dec 31, 2022 | $46.6B |
| FY2023, ended Dec 31, 2023 | $46.1B |
| FY2024, ended Dec 31, 2024 | $43.2B |
| FY2025, ended Dec 31, 2025 | $45.9B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $39.0B |
Revenue
By fiscal year, then the trailing 12 months
Show tableHide table
| Period | Revenue |
|---|---|
| FY2016, ended Dec 31, 2016 | $52.4B |
| FY2017, ended Dec 31, 2017 | $49.5B |
| FY2018, ended Dec 31, 2018 | $47.4B |
| FY2019, ended Dec 31, 2019 | $49.7B |
| FY2020, ended Dec 31, 2020 | $43.7B |
| FY2021, ended Dec 31, 2021 | $52.2B |
| FY2022, ended Dec 31, 2022 | $30.0B |
| FY2023, ended Dec 31, 2023 | $27.9B |
| FY2024, ended Dec 31, 2024 | $27.3B |
| FY2025, ended Dec 31, 2025 | $26.8B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $26.6B |
Net income and free cash flow
By fiscal year, then the trailing 12 months. Free cash flow is operating cash flow minus capex.
Show tableHide table
| Period | Net income | Free cash flow |
|---|---|---|
| FY2016, ended Dec 31, 2016 | −$849M | $2.38B |
| FY2017, ended Dec 31, 2017 | −$6.08B | −$8.30B |
| FY2018, ended Dec 31, 2018 | −$6.00M | −$762M |
| FY2019, ended Dec 31, 2019 | $3.35B | −$2.11B |
| FY2020, ended Dec 31, 2020 | −$5.94B | $685M |
| FY2021, ended Dec 31, 2021 | $10.4B | $5.88B |
| FY2022, ended Dec 31, 2022 | $10.2B | $3.92B |
| FY2023, ended Dec 31, 2023 | $3.64B | $6.00B |
| FY2024, ended Dec 31, 2024 | −$1.40B | — |
| FY2025, ended Dec 31, 2025 | $3.10B | — |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.96B | — |
Cash and cash equivalents
At each fiscal year end, then the latest quarter end.
Show tableHide table
| Period | Cash and cash equivalents |
|---|---|
| FY2016, ended Dec 31, 2016 | $2.11B |
| FY2017, ended Dec 31, 2017 | $2.74B |
| FY2018, ended Dec 31, 2018 | $3.36B |
| FY2019, ended Dec 31, 2019 | $3.29B |
| FY2020, ended Dec 31, 2020 | $3.23B |
| FY2021, ended Dec 31, 2021 | $2.43B |
| FY2022, ended Dec 31, 2022 | $1.57B |
| FY2023, ended Dec 31, 2023 | $1.57B |
| FY2024, ended Dec 31, 2024 | $1.37B |
| FY2025, ended Dec 31, 2025 | $1.34B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $1.56B |
Total debt
At each fiscal year end, then the latest quarter end. Short- and long-term borrowings, excluding leases.
Show tableHide table
| Period | Total debt |
|---|---|
| FY2016, ended Dec 31, 2016 | $30.9B |
| FY2017, ended Dec 31, 2017 | $31.6B |
| FY2018, ended Dec 31, 2018 | $34.5B |
| FY2019, ended Dec 31, 2019 | $35.4B |
| FY2020, ended Dec 31, 2020 | $37.5B |
| FY2021, ended Dec 31, 2021 | $30.2B |
| FY2022, ended Dec 31, 2022 | $28.7B |
| FY2023, ended Dec 31, 2023 | $10.9B |
| FY2024, ended Dec 31, 2024 | $8.92B |
| FY2025, ended Dec 31, 2025 | $9.19B |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | — |
Shares outstanding
At each fiscal year end, then the latest quarter end, adjusted for splits. Down 46.6% since FY16.
Show tableHide table
| Period | Shares outstanding |
|---|---|
| FY2016, ended Dec 31, 2016 | 980M |
| FY2017, ended Dec 31, 2017 | 902M |
| FY2018, ended Dec 31, 2018 | 869M |
| FY2019, ended Dec 31, 2019 | 873M |
| FY2020, ended Dec 31, 2020 | 865M |
| FY2021, ended Dec 31, 2021 | 815M |
| FY2022, ended Dec 31, 2022 | 737M |
| FY2023, ended Dec 31, 2023 | 681M |
| FY2024, ended Dec 31, 2024 | 593M |
| FY2025, ended Dec 31, 2025 | 537M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | 523M |
Buybacks and new shares
By fiscal year, then the trailing 12 months, in dollars. Below zero: bought back. Above zero: issued to employees, sold or used in acquisitions.
Show tableHide table
| Period | Bought back | Paid to employees |
|---|---|---|
| FY2016, ended Dec 31, 2016 | $11.5B | $237M |
| FY2017, ended Dec 31, 2017 | $6.28B | $353M |
| FY2018, ended Dec 31, 2018 | $1.74B | $337M |
| FY2019, ended Dec 31, 2019 | $0 | $314M |
| FY2020, ended Dec 31, 2020 | $500M | $274M |
| FY2021, ended Dec 31, 2021 | $2.59B | $278M |
| FY2022, ended Dec 31, 2022 | $5.20B | $288M |
| FY2023, ended Dec 31, 2023 | $2.96B | $199M |
| FY2024, ended Dec 31, 2024 | $6.65B | $211M |
| FY2025, ended Dec 31, 2025 | $5.84B | $207M |
| Trailing 12 months to Jun 30, 2026 (through Q2 FY2026) | $2.98B | — |
Valuation
At current price- Market Cap
- $41.6B
- P/E
- 14.0×
- Forward P/E
- —. Needs analyst estimates; not available from the current data provider
- Price / Sales
- 1.6×
- Price / Book
- 1.0×
- EV / EBITDA
- —. (Market cap + debt − cash) / EBITDA (TTM)
Growth
Trailing 12 months- Revenue (TTM)
- $26.6B
- Revenue Growth YoY
- −4.2%
- Revenue CAGR 3Y
- −3.7%
- Revenue CAGR 5Y
- −9.3%
- EPS Growth YoY
- 8.1%
- Net Income Growth YoY
- −7.3%
Profitability
Trailing 12 months- Gross Margin
- —
- Operating Margin
- —
- Net Margin
- 11.1%
- FCF Margin
- —. Free cash flow / revenue
- Return on Equity
- 7.2%
Earnings
Trailing 12 months- Net Income
- $2.96B
- EPS (diluted)
- $5.48
- EBITDA
- $7.52B
- Operating Income
- —
Balance Sheet
As of Jun 30, 2026- Cash and cash equivalents
- $1.56B
- Total Debt
- —. Short- and long-term borrowings, excluding leases
- Net Cash
- —. Cash − total debt
- Total Assets
- $163B
- Total Liabilities
- $123B
- Shareholders' Equity
- $40.6B
Cash Flow
Trailing 12 months- Operating Cash Flow
- $3.85B
- Capital Expenditure
- —
- Free Cash Flow
- —. Operating cash flow − capital expenditure
Dividends and risk
Last 12 months- Dividend Yield
- 2.4%
- Dividend / Share
- $1.90
- Beta (5Y)
- 0.52
Every ratio is calculated from the company’s reported figures.